February 10, 2023

Aristea Therapeutics Announces Discontinuation of RIST4721 Development Program and Decision to Dissolve the Company

Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company advancing novel therapies to treat serious inflammatory diseases, today announced that, due to safety findings in the ongoing Phase 2 clinical trials, it has discontinued the RIST4721 development program in order to protect patient safety. read more →

November 2, 2022

Aristea Therapeutics Strengthens its Team with Appointments of Executive Medical Director and Two Clinical Scientists as Clinical Programs Progress

Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company advancing novel therapies to treat serious inflammatory diseases, today announced the appointments of three experienced drug development experts to key positions as it works to progress and expand its clinical pipeline: Himanshu Patel, D.O., as Executive Medical Director, Jennifer Barnes, Ph.D., as Senior Director, Clinical Science, and Walter Frank Eng, PharmD, as Associate Director, Clinical Science. read more →

Scrip Pharma Intelligence

January 4, 2023

Scrip Asks…What Does 2023 Hold For Biopharma? Part 1: The Funding Environment

“I expect that we will see more flat or down rounds with private life science companies in early 2023 as companies get to the end of their cash runway and need additional funding to take them to data catalysts. Many of these rounds will likely be insider rounds with existing investors. Once we see the IPO market re-open, which I expect will happen in H2 2023, then we will likely see more money start to flow into both public and private life science companies and we will start to see valuations increase,” said James Mackay, CEO of Aristea Therapeutics, Inc. read more →

PharmaLive

December 13, 2022

Pharma people on the move: Fall 2022 roundup

San Diego-based Aristea Therapeutics has appointed three experienced drug development experts to key positions. Himanshu Patel, D.O., is executive medical director; Jennifer Barnes, Ph.D., is senior director, clinical science; and Walter Frank Eng, Pharm.D., is associate director, clinical science. read more →